Accelerate Cell Line Development with GPEx® Lightning: Speed, Stability, and Industry-Leading Titers

Accelerate Cell Line Development with GPEx® Lightning: Speed, Stability, and Industry-Leading Titers

Download the offering sheet to see how GPEx® Lightning can accelerate your path to the clinic and beyond.

Catalent’s GPEx® Lightning platform delivers stable, high-yield cell lines with unmatched speed—achieving titers up to 15g/L for mAbs and 11g/L for bispecifics. With 25-day pool generation and up to 12 weeks saved on development timelines, this offering sheet outlines key performance metrics and benefits that make GPEx® Lightning a game-changer for biologics developers.

Learn more about:

  • Understand the critical factors that influence optimal placement of clinical supplies
  • Compare and contrast the fundamental differences between the EU and the UK for clinical supplies
  • Learn to examine various scenarios to better understand which variables most influence country selection
Accelerate Cell Line Development